Cargando…
Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center
BACKGROUND: To investigate the efficacy and safety of biologics in the perioperative management of severe aortic valve regurgitation (AR) caused by Behçet syndrome (BS). METHODS: We retrospectively analyzed 20 patients with severe AR caused by BS who were all treated with biologics during the periop...
Autores principales: | Sun, Luxi, Liu, Jinjing, Jin, Xiufeng, Wang, Zhimian, Li, Lu, Bai, Wei, Yang, Yunjiao, Wu, Chanyuan, Chen, Wei, Xu, Shangdong, Zheng, Jun, Zheng, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221692/ https://www.ncbi.nlm.nih.gov/pubmed/34221307 http://dx.doi.org/10.1177/20406223211026753 |
Ejemplares similares
-
Tocilizumab in the treatment of severe and refractory parenchymal
neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020) -
Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease
por: Li, Lu, et al.
Publicado: (2021) -
Aortic regurgitation due to aortic valve perforation and aortitis in Behçet’s disease
por: Kakiuchi, Minami, et al.
Publicado: (2021) -
Effectiveness and safety of low-dose interferon alpha-2a treatment in
Behçet’s Syndrome with refractory vascular or neurological involvement: a case
series
por: Sun, Luxi, et al.
Publicado: (2022) -
Congenital quadricuspid aortic valve associated with aortic insufficiency and mitral regurgitation
por: Zhu, Jiaquan, et al.
Publicado: (2013)